AGN.AU Argenica Therapeutics Ltd
Market Closed 04-17 16:12:00 AEST
0.68
+0.00
0.00%
High0.70Low0.68Vol42.02K
Open0.69D1 Closing0.68Amplitude2.94%
Mkt Cap87.10MTradable Cap62.24MTotal Shares128.09M
T/O28.75KT/O Rate0.05%Tradable Shares91.53M
P/B6.60ROE-53.14%EPS-0.04
52wk High0.9952wk Low0.54P/E-15.11
Dividend0.00Div.Yield0.00ROA-29.50%
Argenica Therapeutics Says Final Patient Dosed in Phase Two Acute Ischaemic Stroke Drug Candidate Trial; Shares Rise 3%
MT Newswires Live  ·  04-11
Argenica Therapeutics Says Final Patient Dosed in Phase Two Acute Ischaemic Stroke Drug Candidate Trial; Shares Rise 3%
Friday’s HotCopper Trends: MTM soars, ‘outstanding’ Legacy Drake results | April 11, 2025
The Market Herald  ·  04-11
Friday’s HotCopper Trends: MTM soars, ‘outstanding’ Legacy Drake results | April 11, 2025
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans
Simply Wall St.  ·  02-06
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans
Argenica Therapeutics Reports Positive Results From Preclinical Study for Traumatic Brain Injury
MT Newswires Live  ·  02-04
Argenica Therapeutics Reports Positive Results From Preclinical Study for Traumatic Brain Injury
Argenica rat brain study shows potential neuroprotective action in ARG-007
The Market Herald  ·  02-04
Argenica rat brain study shows potential neuroprotective action in ARG-007
REFILE-BUZZ-Argenica Therapeutics rises on approval to continue trials from safety board
Reuters  ·  01-30
REFILE-BUZZ-Argenica Therapeutics rises on approval to continue trials from safety board
Argenica Therapeutics' Phase Two Stroke Trial Gets Safety Board Nod; Shares Rise 4%
MT Newswires Live  ·  01-30
Argenica Therapeutics' Phase Two Stroke Trial Gets Safety Board Nod; Shares Rise 4%
Argenica Therapeutics advances Phase 2 stroke trial after DSMB approval
Grafa  ·  01-29
Argenica Therapeutics advances Phase 2 stroke trial after DSMB approval
Argenica Therapeutics hits safety milestone in Phase 2 trial of stroke therapy ARG-007
Grafa  ·  2024-10-31
Argenica Therapeutics hits safety milestone in Phase 2 trial of stroke therapy ARG-007
ASX Market Close: Inflation falls back within RBA target band | October 30, 2024
The Market Herald  ·  2024-10-30
ASX Market Close: Inflation falls back within RBA target band | October 30, 2024
FDA awards Argenica two key designations for drug candidate targeting infant brain injury
The Market Herald  ·  2024-10-30
FDA awards Argenica two key designations for drug candidate targeting infant brain injury
Argenica Therapeutics Ltd-FDA Grants Odd & Rpdd for Second Drug in Treatment of Hie
THOMSON REUTERS  ·  2024-10-30
Argenica Therapeutics Ltd-FDA Grants Odd & Rpdd for Second Drug in Treatment of Hie
Making money: How many microcaps should be in an investor’s portfolio?
The Market Herald  ·  2024-10-25
Making money: How many microcaps should be in an investor’s portfolio?

Introduction

Company Name.
Argenica Therapeutics Ltd
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Issue price:
--
Invest in Global Markets with Tiger Brokers!
Open App